Advertisement

Topics

Healthcare Disrupter VIOME Raises $15 Million In Series A Funding

06:21 EDT 2 Aug 2017 | PR Newswire

NEW YORK, Aug. 2, 2017 /PRNewswire/ -- VIOME, the AI powered wellness service providing unprecedented insights into your personal health, has raised $15 million in Series A funding to support the launch of its at-home health kit, specifically targeting the Microbiome. VIOME is currently operating as an early beta program with several thousand customers actively using the product. Interested customers can sign up today as the company plans to announce wide availability in the US, UK, Canada, India and Middle East starting in September.

The new round brings VIOME's total funding to $21 Million led by Khosla Ventures with participation from Bold Capital Partners. Khosla Ventures, led by managing partner Vinod Khosla, will receive one seat on the VIOME board.

"VIOME is a transformational healthcare company with a team that comprises decades of experience across AI, health and science, and a singular mission of keeping people healthy," says Vinod Khosla. "By investing in VIOME, we're investing in a future where preventable illnesses are a thing of the past."

VIOME uses state-of-the-art proprietary technology licensed exclusively through its partnership with the prestigious Los Alamos National Laboratory. Its services offer unparalleled visibility into the ecosystem of the body to create unique molecular profiles for its subscribers. VIOME identifies and quantifies all microorganisms in the gut, but more importantly, analyzes what they are actually doing. By applying machine learning to this analysis, VIOME then makes personalized nutritional recommendations to balance the gut microbiome and ecosystem inside the body.

These results offer complete transparency into your own health and the nutrition you need to prevent many of today's chronic illnesses. With this insight, illness can become a choice - a matter of your own decisions.

"Los Alamos National Laboratory has exclusively licensed our advanced transcriptome technology to Viome which allows rapid identification of micro-organisms and their metabolic activities," says Duncan McBranch, Chief Technology Officer at Los Alamos National Laboratory. "This technology was originally developed by leading scientists at the lab to address our national security challenges, and with VIOME's focus on personalized healthcare, it can be used to maintain good health and to prevent chronic disease."

With 45 employees located in Cupertino, Los Alamos, and New York, VIOME was founded by a group of leading entrepreneurs in science and technology. This includes innovator, philanthropist and founder of Moon Express, Intelius, TalentWise and InfoSpace, Naveen Jain.

"Modern healthcare is really symptom-care. It puts the needs of the system – hospitals and insurance companies, above the patient," says Jain, who serves as CEO. "With VIOME, we're allowing people to reclaim control of their health so that chronic illness can become a choice rather than just a matter of bad luck."

Building an expert team, VIOME's leadership includes Chief Technology Officer Guruduth Banavar, who led the creation of Watson AI technologies at IBM, before joining VIOME to apply these technologies to enhance human wellness.

Chief Science Officer Momo Vuyisich brings more than 25 years of R&D experience in many scientific disciplines. He was most recently a scientist and leader of the Applied Genomics team at Los Alamos National Laboratory. Chief Medical Officer Helen Messier is a national leader in personalized "omics"-based medical care, previously serving as medical director, Genomics at Human Longevity, Inc.

VIOME also counts Mark Hyman (Cleveland Clinic Center for Functional Medicine), Dave Asprey (Founder of Bulletproof), Aubrey De Grey (Biomedical Gerontologist), Dallas Hartwig (New York Times Best-Selling Author), and Dr. Tom O'Bryan (Founder of theDr.com) as ambassadors.

Receiving 365 days of wellness a year from VIOME, people are empowered to achieve their goals and live a more informed, healthy and happy life. Learn more atVIOME.com.

Media ContactFactory PR // viome@factorypr.com

About VIOMEVIOME is a wellness service that applies artificial intelligence to complex biological data to provide personalized diet, nutrition and lifestyle recommendations for healthy living.

VIOME tailors its service to evaluate and pinpoint potential issues in the body related to the Microbiome, which tunes our immune system, keeps us under control and reduces inflammation. VIOME specifically targets the bacteria, viruses, yeast, fungus and mold in our system that works symbiotically with the body to provide the nutrition needed to feel energetic and stay healthy.

About Naveen JainNaveen Jain is an entrepreneur and philanthropist driven to solve the world's biggest challenges and epidemics through innovation. To date, he has founded several companies revolutionizing the science, technology and medicine arenas. They include Moon Express, BlueDot, VIOME, Intelius, Talent Wise and InfoSpace.

Naveen is a trustee of the board at the XPRIZE Foundation where he recently launched a million-dollar Women Safety XPRIZE to empower women around the world. In addition, Naveen is also on the board of Singularity University and has been awarded many honors for his accomplishments and entrepreneurial successes.

About KhoslaKhosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies. The firm was founded in 2004 by Vinod Khosla, co-founder of Sun Microsystems. With over four billion dollars under management, the firm focuses on a broad range of areas including consumer, enterprise, education, advertising, financial services, semiconductors, health, big data, agriculture/food, sustainable energy and robotics. Khosla Ventures is headquartered in Menlo Park, Calif.

About BOLD Capital PartnersBOLD Capital Partners ("BOLD"), is a venture capital firm targeting investments in early stage and growth technology companies. BOLD is particularly interested in entrepreneurial leaders that leverage exponential technologies to transform the world and create innovative solutions to humanities' grand challenges. The investment platform leverages the resources of Singularity University (www.su.org) and the Peter Diamandis ecosystem (www.diamandis.com) to actively seek and support world-class entrepreneurs. BOLD has offices in Santa Monica and Palo Alto, California.

View original content with multimedia:http://www.prnewswire.com/news-releases/healthcare-disrupter-viome-raises-15-million-in-series-a-funding-300498365.html

SOURCE VIOME

NEXT ARTICLE

More From BioPortfolio on "Healthcare Disrupter VIOME Raises $15 Million In Series A Funding"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Antiretroviral therapy
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...